Company: NEOG
Filing Date: 2025-01-10
Form Type: NT 10-Q
Source: 0000950170-25-004136
Chunk: 3

Company: NEOGEN CORP
Filing Date: 2025-01-10
Form: NT 10-Q
Chunk 3
---
 Section 21E of the Securities Exchange Act of 1934, as amended. This specifically includes the Company’s expectation of the goodwill impairment charge to be taken in Q2 FY25 and the actual net loss the Company will report for Q2 FY25.

These forward-looking statements are based on Neogen’s current expectations and are subject to risks and uncertainties, which could cause actual results to differ from those stated or implied by such forward-looking statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary from those indicated or anticipated by such forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ from such forward-looking statements include, among others, the finalization of our interim goodwill impairment analysis, the possibility that the Company will not be able to file its Form 10-Q within the five-day extension permitted by the rules of SEC, the occurrence of subsequent events, and other risk factors detailed from time to time in Neogen’s reports filed with the SEC. The foregoing list of important factors is not exclusive.

Any forward-looking statements speak only as of the date of this Form 12b-25. Neogen expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.